Lata Chauhan

620 total citations
15 papers, 489 citations indexed

About

Lata Chauhan is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Lata Chauhan has authored 15 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Cell Biology. Recurrent topics in Lata Chauhan's work include Endoplasmic Reticulum Stress and Disease (4 papers), Cancer therapeutics and mechanisms (3 papers) and Acute Myeloid Leukemia Research (3 papers). Lata Chauhan is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Cancer therapeutics and mechanisms (3 papers) and Acute Myeloid Leukemia Research (3 papers). Lata Chauhan collaborates with scholars based in United States, Egypt and India. Lata Chauhan's co-authors include Rekha Rao, Kapil N. Bhalla, Warren Fiskus, Jatinder K. Lamba, Peng Huang, Min Shen, Kami J. Maddocks, John C. Byrd, Mondana Ghias and Soumyasri Das Gupta and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Lata Chauhan

14 papers receiving 487 citations

Peers

Countries citing papers authored by Lata Chauhan

Since Specialization

Citations

This map shows the geographic impact of Lata Chauhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lata Chauhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lata Chauhan more than expected).

Fields of papers citing papers by Lata Chauhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lata Chauhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lata Chauhan. The network helps show where Lata Chauhan may publish in the future.

Co-authorship network of co-authors of Lata Chauhan

This figure shows the co-authorship network connecting the top 25 collaborators of Lata Chauhan. A scholar is included among the top collaborators of Lata Chauhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lata Chauhan. Lata Chauhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial 2019 ·Blood Cancer Journal ·(unknown), Lata Chauhan, Todd A. Alonzo, Yi-Cheng Wang, (unknown), Michael R. Loken, Jessica A. Pollard, Richard Aplenc, Susana C. Raimondi, Betsy Hirsch, Irwin D. Bernstein, Alan S. Gamis, Soheil Meshinchi, Jatinder K. Lamba	27
2	CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children’s Oncology Group 2019 ·JCO Precision Oncology ·Lata Chauhan, (unknown), Yi-Cheng Wang, Michael R. Loken, Jessica A. Pollard, Richard Aplenc, Betsy Hirsch, Susana C. Raimondi, Rhonda E. Ries, Irwin D. Bernstein, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi, Jatinder K. Lamba	11
3	Drug Transporter ABCB1 SNP Predicts Outcome in Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozagamicin: A Report from Children's Oncology Group AAML0531 Trial 2017 ·Blood ·Lata Chauhan, Todd A. Alonzo, Jim J. Wang, Michael R. Loken, Jessica A. Pollard, Richard Aplenc, Susana C. Raimondi, Roland B. Walter, Betsy Hirsch, Irwin D. Bernstein, Alan S. Gamis, Soheil Meshinchi, Jatinder K. Lamba	1
4	CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children’s Oncology Group Trial AAML0531 2017 ·Journal of Clinical Oncology ·Jatinder K. Lamba, Lata Chauhan, (unknown), Michael R. Loken, Jessica A. Pollard, Yi-Cheng Wang, Rhonda E. Ries, Richard Aplenc, Betsy Hirsch, Susana C. Raimondi, Roland B. Walter, Irwin D. Bernstein, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi	102
5	MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients 2016 ·Frontiers in Pharmacology ·(unknown), Lata Chauhan, (unknown), Xueyuan Cao, Stanley Pounds, Vishal Lamba, Jatinder K. Lamba	19
6	Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity 2015 ·BMC Genomics ·Lata Chauhan, Gregory D. Jenkins, (unknown), (unknown), (unknown), Brooke L. Fridley, Jatinder K. Lamba	9
7	Cytochrome P450 2B65 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma 2015 ·Biology of Blood and Marrow Transplantation* ·Veronika Bachanová, Ryan Shanley, (unknown), Lata Chauhan, Vishal Lamba, Daniel J. Weisdorf, Linda J. Burns, Jatinder K. Lamba	12
8	Cflar Splicing SNP As Predictor of Chemo-Sensitivity to Anticancer Drugs 2015 ·Blood ·Lata Chauhan, (unknown), Jatinder K. Lamba	1
9	Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia 2014 ·Cancer Research ·Warren Fiskus, Nakhle S. Saba, Min Shen, Mondana Ghias, Jinyun Liu, Soumyasri Das Gupta, Lata Chauhan, Rekha Rao, Sumedha Gunewardena, (unknown), Christopher P. Austin, Kami J. Maddocks, John C. Byrd, Ari Melnick, Peng Huang, Adrian Wiestner, Kapil N. Bhalla	198
10	A Qualitative and Quantitative Assay to Study DNA/Drug Interaction Based on Sequence Selective Inhibition of Restriction Endonucleases 2013 ·Tropical Journal of Pharmaceutical Research ·(unknown), Lata Chauhan, Ritu Barthwal, Aparna Dixit	2
11	Cflar Genetic Variant Resulting In Alternate Splicing Determines Isoform Specific Production Of H-Cflar Protein and Is Predictive Of Cellular Cytoxicity Of Triptolide In Hapmap Lymphoblast and AML Cell Lines 2013 ·Blood ·Lata Chauhan, Brooke L. Fridley, (unknown), (unknown), (unknown), Jatinder K. Lamba	0
12	Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells 2012 ·Molecular Cancer Therapeutics ·Rekha Rao, Ramesh Balusu, Warren Fiskus, Uma Mudunuru, Sreedhar Venkannagari, Lata Chauhan, (unknown), Stacey L. Hembruff, Kyungsoo Ha, Peter Atadja, Kapil N. Bhalla	96
13	Abstract 2078: Treatment with auranofin induces oxidative and lethal endoplasmic reticulum (ER) stress exerting single agent activity against mantle cell lymphoma cells 2012 ·Cancer Research ·(unknown), Lata Chauhan, Warren Fiskus, Ramesh Balusu, (unknown), Sreedhar Venkannagari, Siddhartha Ganguly, Kapil N. Bhalla	1
14	Abstract S3-7: Treatment with Histone Deacetylase Inhibitors Creates ‘BRCAness’ and Sensitizes Human Triple Negative Breast Cancer Cells to PARP Inhibitors and Cisplatin 2012 ·Cancer Research ·Kapil N. Bhalla, Rekha Rao, Priyanka Sharma, (unknown), Lata Chauhan, Shane R. Stecklein, Warren Fiskus	7
15	Treatment with Auranofin Induces Oxidative and Lethal Endoplasmic Reticulum (ER) Stress Exerting Single Agent Activity Against Primary CLL Cells 2011 ·Blood ·Rekha Rao, Kami J. Maddocks, Amy J. Johnson, Lata Chauhan, Suman Kambhampati, Siddhartha Ganguly, Ruben Reyes, Omar S. Aljitawi, (unknown), (unknown), Eileen D. Dickman, John C. Byrd, Kapil N. Bhalla	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact